期刊文献+

心脉龙与毒毛旋花子甙K、氨吡酮的急性毒性比较 被引量:2

Toxicity of Xinmailong Compared with that of K-strophanthin and Amrinone
下载PDF
导出
摘要 心脉龙是我院药理教研室研制的供注射用的强心升压药,对该药的急性毒性与同类常用药毒毛旋花子甙K、氨吡酮进行比较,在相同的条件下测得LD50(半数致死量):心脉龙=535.6733±73.7622mg/千克体重,毒毛旋花子甙K=2.8622±0.3774mg/千克体重,氨吡酮=114.4854±9.4279mg/千克体重。心脉龙、毒毛旋花子甙K、氨吡酮的治疗指数分别为505;20;153。表明:心脉龙的安全度比毒毛旋花子甙K大25倍,比氨吡酮大3倍。 Xinmailong is a kind of cardiotonic pressor medicine for injection invented by the Department of Pharmacology of Dali Medical College. We tested the toxicity LD50 of Xinmailong and the other two most commonly used medicines under the same condition. The result is as follows:LD50 in Xinmailong= 535. 6733mg/kg; LD50 in K-Strophanthin=2. 8622mg/kg; LD50 in Amrinone=114. 485mg/kg. The therapeutical index of Xinmailong is 505,K Strophanthin 20,amrinone 153. It shows that Xinmailong is 25 times safer than K Strophanthin,and three times safer than amrinone.
出处 《大理学院学报(医学版)》 1994年第3期1-3,55,共4页
关键词 心脉龙 毒毛旋花子甙K 氨吡酮 急性毒性 Xinmailong K-strophanthin amrinone LD50
  • 相关文献

同被引文献46

  • 1周云桂,吴建新,钮荣祥,沈惠芬,陈海滨.“心脉龙注射液”预防家兔肾上腺素性肺水肿的实验研究[J].中国病理生理杂志,1995,11(3):233-233. 被引量:13
  • 2李立志.陈可冀治疗充血性心力衰竭经验[J].中西医结合心脑血管病杂志,2006,4(2):136-138. 被引量:189
  • 3熊旭东 赵晖.心脉隆注射液对野百合碱引起的肺动脉高压的作用.中国中医药科技,1998,5(5):293-293.
  • 4严奉祥,张华明,李树楠,等.心脉隆对离体大鼠心脏的强心和增加冠脉流量的作用[J].大理医学院学报,1992,1(1):1-4.
  • 5周琦,张竹华,刘红旭,等.有创血流动力学监测评价抗心衰治疗中药心脉隆注射液的临床研究[J].中西医结合心脑血管病杂志,2016,14(4):245—246.
  • 6Hunt SA, Albraham WT, Chin MH, et al. ACC/AHA 2005 guideline update for the diagnosis and man- agement of chronic heart failure in the adult.a re- port of the American College of Cardiology/Ameri- can Heart Association Task Force on Practice Guidelines (Writing Committee to Update 2001 Guidelines for the Evaluation and Management of Heart Failure) :developed in collaboration with the American College of Chest Physicians and the In- ternational Society for Heart and Lung Transplan- tation= endorsed by Heart Rhythm Society [J].Cir-c ulation ,2005,112 ( 12 ) :el 54 - e235.
  • 7卢统庆,赵莹,李艳,等.心脉隆注射液改善扩张型心肌病左室射血分数的临床研究[J].药物与临床,2013,4:218.
  • 8Dobre M, Yang W, Pan Q, et al. Persistent high serum bicarbonate and the risk of heart failure in patients with chronic kidney disease (CKD): A Report from the Chronic Renal Insufficiency Co- hort (CRIC) Study[J]. J Am Heart Assoc, 2015, 4(4) e001599.
  • 9Gupta PP, Fonarow GC, Horwich TB. Obesity and the obesity paradox in heart failure[J]. Can J Car- diol, 2015,31 (2) : 195 -202. Spinar J, Spinarova L, Vtovec J, et al. Compari- son of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure [J]. Vnitr Lek, 2014, 60(4) : 366 -374.
  • 10Spinar J, Spinarov(t L, V~tovec J, et al. Compari- son of American and European (Czech) guidelines for diagnosis and treatment of chronic heart failure EJ~. Vnitr Lek, 20/4, 60(4) : 366 -374.

引证文献2

二级引证文献46

相关作者

内容加载中请稍等...

相关机构

内容加载中请稍等...

相关主题

内容加载中请稍等...

浏览历史

内容加载中请稍等...
;
使用帮助 返回顶部